An antihistamine nasal spray could help ward off COVID-19

Publicly released:
International
Photo by Diana Polekhina on Unsplash
Photo by Diana Polekhina on Unsplash

Regular use of the antihistamine nasal spray Azelastine could reduce your chances of getting COVID-19, according to international research. The researchers recruited 450 people to participate in a study across 2023-2024, with 227 participants using an azelastine spray three times daily for 56 days while the rest were given a placebo spray. Regularly testing the participants for COVID-19, the researchers say five participants from the azelastine group tested positive during the study compared to 15 in the placebo group. They say the results are promising but will need to be tested in larger studies.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Internal Medicine
Research:Paper
Organisation/s: Saarland University, Germany
Funder: Supported by URSAPHARM Arzneimittel GmbH.
Media Contact/s
Contact details are only visible to registered journalists.